Literature DB >> 34563836

Immune function, cortisol, and cognitive decline & dementia in an aging latino population.

Rebecca C Stebbins1, Jessie K Edwards2, Brenda L Plassman3, Y Claire Yang4, Grace A Noppert5, Mary Haan6, Allison E Aiello7.   

Abstract

BACKGROUND: The etiology of dementias and cognitive decline remain largely unknown. It is widely accepted that inflammation in the central nervous system plays a critical role in the pathogenesis of dementia. However, less is known about the role of the peripheral immune system and interactions with cortisol, though evidence suggests that these, too, may play a role.
METHODS: Using data from 1337 participants aged 60+ years from the Sacramento Area Latino Study of Aging (observational cohort) we investigated variation in trajectories of cognitive decline by pathogen IgG and cytokine levels. Linear mixed effects models were used to examine the association between baseline Interleukin (IL)-6, C-reactive protein, tumor necrosis factor (TNF)-α, and five persistent pathogens' IgG response and trajectories of cognition over 10 years, and to examine interactions between immune biomarkers and cortisol. Stratified cumulative incidence functions were used to assess the relation between biomarkers and incident dementia. Inverse probability weights accounted for loss-to-follow-up and confounding.
RESULTS: IL-6, TNF-α, and CMV IgG were statistically significantly associated with a higher log of Modified Mini-Mental State Examination errors (IL-6, β=0.0935 (95%CI: 0.055, 0.13), TNF-alpha β= 0.0944 (95%CI: 0.032, 0.157), and CMV, β= 0.0409 (95%CI: 0.013, 0.069)). Furthermore, cortisol interacted with HSV-1 and IL-6, and CRP for both cross-sectional cognitive function and rate of decline. No statistically significant relationship was detected between biomarkers and incidence of dementia.
CONCLUSIONS: These findings support the theory that the peripheral immune system may play a role in cognitive decline but not incident dementia. Furthermore, they identify specific markers amenable for intervention for slowing decline.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3MSE; Cognition; Dementia; Endocrine pathways; Immune function

Mesh:

Substances:

Year:  2021        PMID: 34563836      PMCID: PMC8600484          DOI: 10.1016/j.psyneuen.2021.105414

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  49 in total

1.  Carotid atherosclerosis, cytomegalovirus infection, and cognitive decline in the very old: a community-based prospective cohort study.

Authors:  Midori Kawasaki; Yasumichi Arai; Michiyo Takayama; Takumi Hirata; Midori Takayama; Yukiko Abe; Hidehito Niimura; Masaru Mimura; Toru Takebayashi; Nobuyoshi Hirose
Journal:  Age (Dordr)       Date:  2016-02-17

Review 2.  Microglial priming in neurodegenerative disease.

Authors:  V Hugh Perry; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Life-course socioeconomic position and incidence of dementia and cognitive impairment without dementia in older Mexican Americans: results from the Sacramento area Latino study on aging.

Authors:  Adina Zeki Al Hazzouri; Mary N Haan; John D Kalbfleisch; Sandro Galea; Lynda D Lisabeth; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

5.  Stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components.

Authors:  A Pappin; M Grissom; W Mackay; Y Huang; R Yomtovian
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

6.  Variables that affect assays for plasma cytokines and soluble activation markers.

Authors:  N Aziz; P Nishanian; R Mitsuyasu; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

Review 7.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

Review 8.  Learning and memory ... and the immune system.

Authors:  Ioana Marin; Jonathan Kipnis
Journal:  Learn Mem       Date:  2013-09-19       Impact factor: 2.460

9.  Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction, and cognitive impairments.

Authors:  Xia Ge; Xiao-yun Xu; Chun-hua Feng; Yue Wang; Yuan-ling Li; Bo Feng
Journal:  BMC Neurol       Date:  2013-08-27       Impact factor: 2.474

10.  Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife.

Authors:  Archana Singh-Manoux; Aline Dugravot; Eric Brunner; Meena Kumari; Martin Shipley; Alexis Elbaz; Mika Kivimaki
Journal:  Neurology       Date:  2014-07-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.